Press Release
ZUBR Has Become a Leader in the NMN Industry at Home and Abroad
As the global economy continues to grow and life expectancy continues to rise, the proportion of elderly people aged 65 years and above continues to increase, and global attention to health issues continues to increase. The life expectancy issue has become one of the ultimate problems that mankind has continued to strive to solve in the history of mankind. In recent years, global academic research has shown that NMN has become a consensus anti-aging health care product.
The full name of NMN is β-nicotinamide mononucleotide, which is the precursor for the synthesis of NAD+ (coenzyme I) in the human body. Since NAD+ is a coenzyme for hundreds of important metabolic enzymes in cells, it also participates in many important cellular processes as a signal molecule. It is closely related to energy metabolism, glycolysis, DNA replication and other activities. NMN can increase the level of NAD+ in the body and is considered a health product with anti-aging functions. Compared with other products, NMN products enhance NAD+ and have the advantages of non-toxic side effects and high conversion efficiency. At present, the academic community has confirmed that NMN has the following 10 major functions: support NAD+ production (NAD+ is an indicator of aging in the body), activate longevity protein/gene SIRTUINS, repair DNA damage, support energy production, enhance metabolism, help enhance physical endurance and vitality, and helps improve blood vessel and muscle physiology, helps weight management, helps brain and heart health, helps improve insulin sensitivity, etc.
As one of the world-class academic achievements, Professor David Sinclair of Harvard University used NMN raw materials and published the research results of NAD+ reversing blood aging in the top academic journal “Cell”. From the age of 30, the NAD+ content in the body decreases significantly. At the age of 60, the level of NAD+ is less than a quarter of that of young people. This means that after 60 years of age, there are many biochemical and metabolic reactions in the human body that cannot be efficiently carried out. Therefore, the older the age, the more health problems become.
How to effectively supplement NMN? According to the FDA’s principle of equivalence, a 70Kg adult should be supplemented with 300mg of NMN per day, and an adult with the same amount of NMN needs to eat 32~128kg of edamame, or 54~240kg of broccoli. It is less efficient to supplement NMN through food sources in nature, and NMN products can achieve this effect faster. After taking NMN in the human body, the study found that the NAD+ content in the body increased significantly after 5 minutes, and the supplement effect was significantly improved.
ZUBR® from the United States is a high-tech company focusing on anti-aging research and product development for a long time. Headquartered in New York, USA, ZUBR® brand Slogan is Anti-aging From Young, advocating the life concept of “anti-aging while young”. ZUBR® introduces anti-aging explosives such as NMN to the United States, Europe and Asia, bringing a healthy lifestyle of “anti-aging while young” to hundreds of millions of middle-class people around the world. ZUBR® has the core production qualifications of health care products such as FDA, NSF GMP, and has mastered core production technology. According to the laboratory test results of US Pharmatech, ZUBR® NMN developed by biological enzymatic method has the characteristics of high purity, high absorption and conversion rate, and the effective purity is higher than that of products in the same industry.
At present, ZUBR® has many flagship products such as NMN Pro and NMN Honor, and the product line fully meets the needs of different users. Among them, the NMN Pro product comes in small bottles, which is currently the only product on the market with a weekly pack (14 capsules) as a unit, which is especially suitable for urban white-collar people to carry during their daily commuting. Each bottle of NMN Pro contains 14 high-concentration NMN capsules, which can be used for a week, and each time it is taken, it can supplement 340mg NMN and 100mg resveratrol. NMN Honor provides a more powerful dose of NMN, suitable for reuse in the morning at home. It can supplement 480mg of NMN and 100mg of resveratrol each time. Each bottle provides 90 capsules for 45 days of continuous use.
Overseas, ZUBR® has won praise from a large number of users with its excellent product strength. Bryan Gunn, an automotive industry designer from Ohio, USA, said, “After taking it, I feel my body is full of vitality, my sleep quality has unexpectedly improved, and I feel my mind is clearer”. Dean Norris, a fund manager from Wall Street in New York, United States, said, “Day 1: 2 capsules in the morning, the body has a significant reaction in the afternoon, and fatigue is reduced; Day 2: 2 capsules in the morning, I feel more clear-headed; 4, 5 days: One hour after each consumption, you can feel your mind becomes clearer and no longer tired; 6th and 7th days: More energy and weight loss than before.” Peter Gould, a Java development engineer from California, said, “Since taking it, I have been very stable and sustained vitality throughout the day. This is an experience I haven’t had before trying other health foods.”
ZUBR® officially entered the Asian market in 2019, using word of mouth as the lifeline of the company’s survival and development. At the same time, in combination with the actual needs of the Asian market, the product price is reduced to a level that can be purchased by the general public while meeting the effective dose. We have reason to believe that ZUBR® will soon become the leading brand in the field of anti-aging health food.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Atlas Healthcare Fund by VST Capital Entered Eli Lilly at $350 in 2020 — The Stock Now Trades Above $1,200
New York, United States, July 15th, 2026, FinanceWire
Atlas Healthcare Fund managed by VST Capital, today highlighted a series of early conviction investment decisions that have defined its track record since launch — none more striking than its position in Eli Lilly and Company, entered at approximately $350 per share in 2020, years before GLP-1 receptor agonists became the most consequential pharmaceutical story of the decade. Eli Lilly now trades above $1,200, a gain of more than 246% from the fund’s entry point.
At the time of purchase, Lilly’s tirzepatide was in Phase II trials with limited analyst coverage and minimal institutional positioning. VST Capital’s investment team had read the data, understood the mechanism, and build the position quietly. The market caught up years later.
“We did not buy Eli Lilly because of a price target,” said Dr. Sarah Morie, Co-Founder and Chief Investment Officer of Atlas Healthcare Fund. “We bought it because our team had read the Phase II data and believed tirzepatide was a genuinely differentiated asset in a disease area that mainstream medicine had chronically underestimated.”
A Pattern of Early Conviction
The Eli Lilly call was not isolated. Alnylam Pharmaceuticals was entered at approximately $110 in 2020, when RNA interference was considered a niche platform with limited commercial application. It reached $491 in October 2025 — a gain of more than 346% from the fund’s entry price — before the broader market had fully understood what the RNAi platform was capable of.
TransMedics Group was identified in 2020 when the company’s organ care platform was largely unknown outside specialist transplant medicine. Entered at approximately $18, the position returned more than 275% from cost as the platform transformed the standard of care for organ transplantation and revenue scaled accordingly.
Inari Medical was entered following the company’s 2020 IPO, when VST Capital’s clinical team identified its thrombectomy device as structurally superior to existing treatment options for venous thromboembolism. The position generated a realised gain of more than 250% when Stryker acquired the company in April 2025 at a significant premium — a validation, in the fund’s view, of exactly what its clinical assessment had concluded five years earlier.
In each case the investment originated not from a financial screen but from a clinical question: is this technology genuinely better than what exists, and does the market understand that yet?
The Track Record
Since inception in January 2020, Atlas Healthcare Fund has delivered a cumulative net return of +1,720.9% through December 2025, averaging more than 57% annually across six full calendar years. The fund is managed by VST Capital and manages approximately $193 million across 38 concentrated positions. Minimum investment is $5,000. No management fee is charged.
About VST Capital
VST Capital is a New York-based investment management firm and the managing entity of Atlas Healthcare Fund. The firm was founded with the conviction that deep clinical and scientific expertise creates durable, repeatable investment advantages in the healthcare sector that generalist investors cannot replicate.
Contact
PR
Valerie Blanchard
VST Capital
pr@vstcapital.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Singapore, Singapore, July 15th, 2026, FinanceWire
TrustFinance Awards today announced the launch of its Verified Recognition framework as part of TrustFinance Awards 2026, introducing a transparent, structured, and verifiable recognition system designed to strengthen credibility across financial industry awards.
The new framework enables organizations to demonstrate that their recognition is supported by a clear evaluation process, addressing the growing demand for greater transparency and trust across the global financial services industry.
Trust has become one of the financial industry’s most valuable assets. As clients increasingly look beyond products and pricing, they expect financial institutions to demonstrate transparency, reliability, and credibility. This shift is also reshaping how industry awards are viewed, with companies and stakeholders asking a more important question:
What makes an award truly credible?
Verified Recognition is built on a simple principle: an award should be valued not only for the title it carries, but also for the integrity of the process behind it.
The TrustFinance Awards framework combines structured evaluation, transparent methodology, governance, and digital verification to ensure recognition is supported by objective, verifiable standards.
As transparency becomes increasingly important across financial services, credible third-party recognition is becoming a stronger signal of trust for clients, investors, and business partners.
“Recognition should represent more than a trophy—it should reflect a transparent process that stakeholders can understand and trust,” said Peter Bu, CEO of TrustFinance. “Verified Recognition reflects our commitment to helping raise the standard of credibility across financial industry awards.”
TrustFinance Awards 2026 features two complementary recognition programs: Performance Awards, which recognize operational excellence through independent evaluation, and Community Choice Awards, which recognize organizations that have earned the trust of the wider community through verified nominations and voting.
Together, they combine independent assessment with community confidence to provide a broader and more balanced approach to recognition.
Recognition should create value long after the awards ceremony. Beyond trophies and certificates, recognized organizations receive digital recognition assets—including verification pages, official award badges, digital certificates, and promotional materials—that can be integrated across websites, marketing campaigns, and business communications, helping transform recognition into an ongoing trust signal rather than a one-time achievement.
TrustFinance Awards is open to organizations across the financial services industry, including forex brokers, fintech companies, investment platforms, payment service providers, digital asset businesses, and other financial institutions.
The program includes three annual Performance Awards recognition cycles—Spring Recognition, Summer Recognition, and Year-End Recognition—alongside the annual Community Choice Awards, recognizing organizations that have earned the confidence of the wider community.
As the financial industry continues to evolve, TrustFinance believes recognition should be more than a symbol of achievement—it should be a trusted signal of credibility, built on transparency, independent evaluation, and verifiable standards.
Learn more about TrustFinance Awards 2026 at TrustFinance Awards 2026
About TrustFinance
TrustFinance is a global financial intelligence platform dedicated to improving transparency and trust across the financial services industry. Through verified customer reviews, TrustScore, regulatory information, company insights, and independent recognition programs, TrustFinance helps investors make more informed decisions while enabling financial institutions to strengthen credibility and build long-term trust.
For more information, visit https://www.trustfinance.com.
About TrustFinance Awards
TrustFinance Awards is a global recognition program that celebrates excellence across the financial services industry. The program consists of two complementary recognition programs: Performance Awards, which recognize organizations through independent evaluation, and Community Choice Awards, which recognize organizations through verified community nominations and voting. Built on the principles of Verified Recognition, the program promotes transparency, objective assessment, and verifiable recognition to help strengthen trust across the global financial industry.
Learn more at https://awards.trustfinance.com.
Contact
TrustFinance Awards
TrustFinance
awards@trustfinance.com
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
The Bascom Group Acquires 183-Unit Value-Add Apartment Community In Buena Park, California For $53.125 Million
United States, 15th Jul 2026 – The Bascom Group, LLC (“Bascom”) has acquired Castlewood Park Apartments, a low-density, 183-unit value-add apartment community in the highly desirable Orange County investment market of Buena Park, California. The purchase price was $53,125,000, or $290,301 per unit. Brian Eisendrath, Cameron Chalfant, Jesse Zarouk, and Jake Vitta of IPA Capital Markets arranged the acquisition financing, with Brightspire Capital, Inc. The IPA Investment Sales team led by Kevin Green and Joe Grabiec represented the seller. AMC will provide property management services for the community, while SD-Cap will oversee the planned property renovations.
Originally constructed in 1963, Castlewood Park Apartments offers many of the characteristics that are difficult to replicate in today’s new developments. The community features spacious floorplans averaging 1,028 square feet, garages for every unit, and private yards for approximately 60% of residences. Spanning 46 buildings across 8.7 acres, the property’s garden-style design and ultra-low density of just 21 units per acre create a neighborhood-like environment with abundant open space and minimal disturbances from neighboring units. The community consists entirely of two-, three-, and four-bedroom apartments and includes two swimming pools and a leasing center. These attributes provide residents with a compelling, lower-cost alternative to homeownership in one of Southern California’s most supply-constrained housing markets.
Bascom plans to elevate the property through interior renovations, amenity enhancements, and the addition of full-time onsite management to further improve the resident experience. Lee Nguyen, Senior Vice President of Operations for Bascom, stated, “Castlewood already offers many of the features today’s renter values most like large floorplans, garage parking, abundant green space, and private yards. By thoughtfully modernizing the community while preserving these unique characteristics, we believe Castlewood will continue to be a highly desirable housing option for North Orange County residents.”
The Bascom Group got its start in 1996 acquiring apartment communities just like Castlewood. While Bascom has acquired more than 369 multifamily communities across 20 states, the firm’s first 42 acquisitions were concentrated in Southern California, primarily Orange County, with many consisting of older vintage apartment communities. Tim Whiting, Senior Vice President of Operations, added, “Bascom has extensive experience repositioning older vintage communities, completing approximately $110 million of renovations across 44 properties and more than 8,000 apartment homes. Properties like Castlewood remain an important part of Orange County’s housing stock, and our focus is on making strategic improvements that enhance the resident experience while preserving an affordable housing option in a highly desirable market.”
Castlewood Park is in North Orange County with immediate access to the 5 and 91 freeways, placing residents near major employment centers throughout Orange County and Los Angeles. The surrounding neighborhood includes a newly developed KB Home townhome community and established single-family neighborhoods with home values ranging from approximately $900,000 to more than $1 million.
Chad Sanderson, Senior Principal at Bascom, added, “Institutional investors have become increasingly selective toward older apartment communities, creating attractive buying opportunities for experienced value-add operators. We believe well-located, older vintage properties in Orange County are being discounted more than fundamentals justify. Castlewood represents an opportunity to acquire a durable workforce housing asset at an attractive basis in one of the strongest apartment markets in the country.”
While many institutional buyers have remained on the sidelines during the multifamily pricing reset following the interest rate increases of 2022 and 2023, Bascom has continued to deploy capital. Since interest rates began rising, Bascom has acquired 13 multifamily communities totaling 3,231 units for more than $930 million. Those acquisitions span properties built from the 1960s through 2024, reflecting Bascom’s ability to identify opportunities across a wide range of investment strategies. The acquisition of Castlewood Park Apartments follows Bascom’s earlier 2026 acquisitions of The Ellison, a 294-unit community in Las Vegas completed in 2024, and Domain 3201, a 289-unit community in Tucson built in 1985 and 1986.
Joe Ferguson, Vice President of Acquisitions for Bascom, stated, “The multifamily market has become much more nuanced over the past few years, and we believe several compelling investment themes have emerged. Whether it is newer communities trading below replacement cost, markets that have reset and are beginning to recover, or older apartment communities in supply-constrained locations that have become overly discounted, we are seeing attractive opportunities across a broad spectrum of the market. We believe today’s pricing environment creates a compelling opportunity to invest ahead of improving market fundamentals.”
About Bascom:
The Bascom Group, LLC is a minority-owned private equity firm specializing in value-added multifamily, commercial, and real estate related investments and operating companies. Bascom sources value-added and distressed properties including many through foreclosure, bankruptcy, or short sales and repositions them by adding capital improvements, improving revenue, and reducing expenses by realizing operational efficiencies through implementation of institutional-quality property management. Bascom, founded by principals Derek Chen, Jerry Fink, and David Kim, is one of the most active and seasoned buyers and operators of apartment communities in the U.S. Since 1996, Bascom has completed over $23.0 billion in multifamily value-added transactions encompassing 368 multifamily properties and over 94,272 units. Bascom’s commercial transaction volume is $5.8 billion in total and amounts to over 23.4 million square feet. Bascom has ranked among the top 50 multifamily owners in the U.S. Bascom’s subsidiaries and joint ventures include the Bascom Value Added Apartment Investors, Shubin Nadal Associates, Spirit Bascom Ventures, REDA Bascom Ventures, Bascom Northwest Ventures, Bascom Arizona Ventures, Harbor Associates, Village Partners Ventures, Realm Group, Commercial Real Estate Services, BG Pearce, and Meridian Investment Group. Bascom’s subsidiaries also include Premier Workspaces, one of the largest privately held executive suite, coworking and shared workspace companies in the U.S. For additional information, please visit bascomgroup.com.
Contact :
Jerome A. Fink
Managing Partner
The Bascom Group, LLC
7 Corporate Park, Suite 100 | Irvine, CA 92606
714-293-0888 (cell) | 949-955-2991 (office)
jfink@bascomgroup.com
www.bascomgroup.com
Media Contact
Organization: The Bascom Group, LLC
Contact Person: Jerome A. Fink
Website: https://bascomgroup.com/
Email: Send Email
Country:United States
Release id:47128
The post The Bascom Group Acquires 183-Unit Value-Add Apartment Community In Buena Park, California For $53.125 Million appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Atlas Healthcare Fund by VST Capital Entered Eli Lilly at $350 in 2020 — The Stock Now Trades Above $1,200
TrustFinance Awards Sets a New Standard for Financial Awards
The Bascom Group Acquires 183-Unit Value-Add Apartment Community In Buena Park, California For $53.125 Million
Benzinga Money Article Discusses How to Become Part of the 12% of Retirees Who Have Achieved the Recommended $550,000 Minimum Retirement Savings Threshold
Apu Apustaja Conquers New York with Lively Street Ads, Including Times Square Billboard
Bay Smokes Maintains Quality Amid Legislative Changes in the Hemp Industry
-
Press Release6 days ago
Vincere Portfolios Highlights Growing Shift Toward Algorithmic Futures Trading Among Independent Investors
-
Press Release1 week ago
813,294 Wallets Lost $2 Billion on the TRUMP Token – The Registered Cut Explains Less Than a Third of the Winnings.
-
Press Release1 week ago
BNBN.pl Ranking: The 10 Fastest-Growing Polish Startups to Watch in 2026
-
Press Release4 days ago
Thriving in Retirement Michael Masor’s Newly Released Book is a Complete Blueprint for Modern Retirement Planning
-
Press Release4 days ago
Ruckaroo Launches World’s First Fitness App Built for Weighted Walking
-
Press Release4 days ago
New Guide Helps Musicians Create a Connected Music Marketing System
-
Press Release4 days ago
Northlake Concierge Medical Center Announces Boutique Class-A Medical Office Development in Tucker, Georgia
-
Press Release4 days ago
Selling Your Business Why More Owners Are Choosing Direct Buyers Instead of Traditional Brokers